Affiliation:
1. N.A. Alekseev Psychiatric Clinical Hospital No. 1, Department of Health of the City of Moscow
Abstract
Catatonia is a common syndrome among psychiatric patients, diagnosed in 20-43% of cases. Treatment methods for patients with catatonia are limited to the use of benzodiazepines and ECT in the acute period, and the problem of anti-relapse and maintenance therapy remains one of the most difficult. Currently, transcranial magnetic stimulation is a promising approach in the treatment of catatonia. The purpose of the study was to evaluate the possibility of using the method of transcranial magnetic stimulation of the brain in patients with schizophrenia in remission with residual catatonic symptoms. Material and methods. 50 patients diagnosed with schizophrenia and residual catatonic symptoms were examined by clinical and psychometric methods and divided into 2 groups (therapeutic and comparison groups) to prospectively evaluate the effectiveness of transcranial magnetic stimulation for 4 weeks. Results. Transcranial magnetic stimulation of the DLPFC on the left in patients with residual catatonia TMS turned out to be effective and safe a tendency was revealed to reduce psychomotor impairments that made up the clinical picture before the start of stimulation, along with an improvement in basic cognitive functions. Conclusions. Augmentation of standard psychopharmacotherapy protocols with TMS is effective for the correction of psychomotor symptoms.
Publisher
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
Reference61 articles.
1. Melnikova, T.S.; Tsukarzi, E.E.; Trushelev, S.A.; Mosolov, S.N. Dynamics of the alpha rhythm of the electroencephalogram during transcranial magnetic stimulation of the brain of patients with resistant depression: 6. Russian Psychiatric Journal. 2019:48–53.
2. Tsukarzi, E.; Ilyin, S.; Mosolov, S. Resistant depression treatment: rTMS vs ECT. European Neuropsychopharmacology. 2005;15:115.
3. Maslenikov, N.; Tsukarzi, E.E.; Mosolov, S.N. Treatment-resistant depression in schizophrenia: clinical response predictors of repetitive transcranial magnetic stimulation (rTMS). European Neuropsychopharmacology. 2017;27:693–694.
4. Maslenikov, N.; Tsukarzi, E.; Mosolov, S. Repetitive transcranial magnetic stimulation for depression in schizophrenia: Focus on cognitive functions. European Neuropsychopharmacology. 2019;29:557–558.
5. Klein, E.; Kreinin, I.; Chistyakov, A.; Koren, D.; Mecz, L.; Marmur, S.; Ben-Shachar, D.; Feinsod, M. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch. Gen. Psychiatry. 1999;56(4):315–320.